Thousands to receive brand new weight loss jab
manchestereveningnews.co.ukHundreds of thousands of people with type 2 diabetes are expected to benefit from a brand new weight loss jab. Tizepatide, also known as Mounjaro, has been green-lighted for NHS use and could help around 180,000 people.
The National Institute for Health and Care Excellence (Nice) said it can help those who don't have the condition under control.
The jab should reportedly be prescribed to patients who are unable to tolerate metformin - the first-line defence medicine for type 2 diabetes - and should be taken alongside diet and exercise.
NHS patients are expected to begin receiving the jab early next year, the Liverpool Echo reports. Try MEN Premium for FREE by clicking here for no ads, fun puzzles and brilliant new features There are 4.3 million people in the UK living with the condition, of which 90 per cent are type 2, according to Diabetes UK.
Read more on manchestereveningnews.co.uk
